181 related articles for article (PubMed ID: 27666772)
21. AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy.
Ono H; Suzuki N; Kanno SI; Kawahara G; Izumi R; Takahashi T; Kitajima Y; Osana S; Nakamura N; Akiyama T; Ikeda K; Shijo T; Mitsuzawa S; Nagatomi R; Araki N; Yasui A; Warita H; Hayashi YK; Miyake K; Aoki M
Mol Ther; 2020 Apr; 28(4):1133-1153. PubMed ID: 32087766
[TBL] [Abstract][Full Text] [Related]
22. Novel, de novo dysferlin gene mutations in a patient with Miyoshi myopathy.
Hu YY; Lian YJ; Xu HL; Zheng YK; Li CF; Zhang JW; Yan SP
Neurosci Lett; 2018 Jan; 664():107-109. PubMed ID: 29138090
[TBL] [Abstract][Full Text] [Related]
23. Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy.
Xi J; Blandin G; Lu J; Luo S; Zhu W; Béroud C; Pécheux C; Labelle V; Lévy N; Urtizberea JA; Zhao C; Krahn M
Neurol India; 2014; 62(6):635-9. PubMed ID: 25591676
[TBL] [Abstract][Full Text] [Related]
24. Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation.
Dominov JA; Uyan Ö; McKenna-Yasek D; Nallamilli BRR; Kergourlay V; Bartoli M; Levy N; Hudson J; Evangelista T; Lochmuller H; Krahn M; Rufibach L; Hegde M; Brown RH
Ann Clin Transl Neurol; 2019 Apr; 6(4):642-654. PubMed ID: 31019989
[TBL] [Abstract][Full Text] [Related]
25. Dysferlin protein analysis in limb-girdle muscular dystrophies.
Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
[TBL] [Abstract][Full Text] [Related]
26. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
Bolduc V; Marlow G; Boycott KM; Saleki K; Inoue H; Kroon J; Itakura M; Robitaille Y; Parent L; Baas F; Mizuta K; Kamata N; Richard I; Linssen WH; Mahjneh I; de Visser M; Bashir R; Brais B
Am J Hum Genet; 2010 Feb; 86(2):213-21. PubMed ID: 20096397
[TBL] [Abstract][Full Text] [Related]
27. Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding Assay.
Anwar S; Yokota T
Methods Mol Biol; 2023; 2587():183-196. PubMed ID: 36401031
[TBL] [Abstract][Full Text] [Related]
28. Structural and ultrastructural changes in the skeletal muscles of dysferlin-deficient mice during postnatal ontogenesis.
Chernova ON; Chekmareva IA; Mavlikeev MO; Yakovlev IA; Kiyasov AP; Deev RV
Ultrastruct Pathol; 2022 Jul; 46(4):359-367. PubMed ID: 35880824
[TBL] [Abstract][Full Text] [Related]
29. Three novel recessive DYSF mutations identified in three patients with muscular dystrophy, limb-girdle, type 2B.
Okubo M; Iida A; Hayashi S; Mori-Yoshimura M; Oya Y; Watanabe A; Arahata H; El Sherif R; Noguchi S; Nishino I
J Neurol Sci; 2018 Dec; 395():169-171. PubMed ID: 30366248
[No Abstract] [Full Text] [Related]
30. New aspects on patients affected by dysferlin deficient muscular dystrophy.
Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
[TBL] [Abstract][Full Text] [Related]
31. Null variants in DYSF result in earlier symptom onset.
Park HJ; Hong YB; Hong JM; Yun U; Kim SW; Shin HY; Kim SM; Choi YC
Clin Genet; 2021 Mar; 99(3):396-406. PubMed ID: 33215690
[TBL] [Abstract][Full Text] [Related]
32. Novel splicing dysferlin mutation causing myopathy with intra-familial heterogeneity.
Rekik S; Sakka S; Romdhane SB; Amer YB; Lehkim L; Farhat N; Mahfoudh KB; Authier FJ; Dammak M; Mhiri C
Mol Biol Rep; 2020 Aug; 47(8):5755-5761. PubMed ID: 32666437
[TBL] [Abstract][Full Text] [Related]
33. Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies.
Assereto S; Mastrototaro M; Stringara S; Gazzerro E; Broda P; Nicchia GP; Svelto M; Bruno C; Nigro V; Lisanti MP; Frigeri A; Minetti C
Cell Cycle; 2008 Jul; 7(14):2199-207. PubMed ID: 18641458
[TBL] [Abstract][Full Text] [Related]
34. A novel dysferlin gene mutation in a Filipino male with Miyoshi myopathy.
Adiao KJ; Prado MB; Astejada M
Clin Neurol Neurosurg; 2021 Feb; 201():106433. PubMed ID: 33348118
[No Abstract] [Full Text] [Related]
35. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
36. Dysferlinopathy in Chile: evidence of two novel mutations in the first reported cases.
Bevilacqua JA; Krahn M; Pedraza L; Gejman R; Gonzalez S; Lévy N
Genet Test Mol Biomarkers; 2009 Feb; 13(1):105-8. PubMed ID: 19309282
[TBL] [Abstract][Full Text] [Related]
37. Two novel mitochondrial DNA mutations in muscle tissue of a patient with limb-girdle myopathy.
Meulemans A; De Paepe B; De Bleecker J; Smet J; Lissens W; Van Coster R; De Meirleir L; Seneca S
Arch Neurol; 2007 Sep; 64(9):1339-43. PubMed ID: 17846276
[TBL] [Abstract][Full Text] [Related]
38. Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.
Sellers SL; Milad N; White Z; Pascoe C; Chan R; Payne GW; Seow C; Rossi F; Seidman MA; Bernatchez P
J Lipid Res; 2018 Feb; 59(2):261-272. PubMed ID: 29175948
[TBL] [Abstract][Full Text] [Related]
39. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
Nalini A; Gayathri N
Neurol India; 2008; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
[TBL] [Abstract][Full Text] [Related]
40. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.
Griffin DA; Johnson RW; Whitlock JM; Pozsgai ER; Heller KN; Grose WE; Arnold WD; Sahenk Z; Hartzell HC; Rodino-Klapac LR
Hum Mol Genet; 2016 May; 25(10):1900-1911. PubMed ID: 26911675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
